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It is well-established that the glomerular filtration rate (GFR)
is increased significantly in insulin-dependent diabetic patients
without nephropathy [1—7], in patients with acromegaly [8, 9]
and during normal pregnancy [10]. GFR is also increased
significantly in subjects with extreme obesity compared to
nonobese controls of similar age, sex, and height [11, 12]. The
mechanism of the increased GFR in these conditions is incom-
pletely understood.
Because the central function of the kidney is to regulate the
composition and volume of the extracellular fluids, it was
recently proposed [13] that the ratio between GFR and the
extracellular fluid volume (ECV) might give additional insight
into the increase of GFR in the above-mentioned conditions.
Using this approach in patients with extreme obesity, GFR and
ECV were found to be increased to the same extent (about
40%); following a period of 1 to 7 years after an intestinal
bypass operation, both GFR and ECV decreased so that renal
function (as assessed by the ratio GFRJECV) was the same
before and after operation and equal to that in nonobese control
patients [12]. Also in patients with acromegaly it has been
reported that the relationship between the increased values of
GFR and ECV is the same as in normal subjects [8].
In the present study GFR, ECV, and the ratio GFRIECV in
insulin-dependent diabetics have been determined and these
results have been compared with those in normal subjects. The
aim was to investigate whether or not the ratio GFRJECV in
diabetic patients is higher than in healthy subjects, that is,
whether or not the increased GFR reflects a real hyperfunction.
Methods
Pertinent observations on the studied diabetic patients and
normal subjects are given in Table 1.
Diabetic patients. Twenty-six diabetic men were investigat-
ed. They had insulin-dependent diabetes for 0.1 to 14 years
(median 3.3 years) and three of the patients had newly diag-
nosed diabetes mellitus. All patients were regulated fairly well,
that is, none were ketotic; the mean fasting blood glucose
averaged 10.9 mmoles/liter with a range from 3.7 to 18.1
mmoles/liter. None had proteinuria when tested with Albustix®.
All diabetic patients had a normal BP and a normal serum
creatinine concentration.
Control patients. Forty-four normal men served as control
patients. They constitute the reference population for normal
renal function used in the Department of Clinical Physiology.
Analysis of the data from these patients showed that the
relation between ECV and body weight and between ECV and
body surface area was independent of age (to be published).
Irrespective of the difference between diabetic and control
patients with respect to age distribution (compare with Table 1),
the values for ECV in all 44 normal men could be used,
therefore, for the comparison with ECV in diabetic patients.
Because GFR changes with age, the values of GFR and
GFRJECV in the 26 diabetic patients were compared to those in
26 normal men selected randomly from the 44 normal men so
that their age distribution corresponded to that in patients with
diabetes mellitus.
Procedure. The diabetic patients were studied after an over-
night fast and the usual morning-dose of insulin was deferred
until the end of the examination. The three patients with newly
diagnosed diabetes were investigated after they had received
insulin in optimal dosages for 10 to 19 days. All diabetic and
control patients were investigated in the supine position in the
morning (from 9 A.M. to 1 P.M.) after a 30-mm rest period. GFR
and the distribution volume of [51Cr] EDTA, as an estimate of
ECV, were determined by a simplified single injection method
[13] with blood sampling 180, 200, 220, and 240 mm after an
intravenous injection of 100 p.Ci [51Cr] EDTA. In diabetic
patients the blood glucose concentration was determined at
time intervals of 30 to 60 mm during the examination. Body
surface area was estimated according to the formula of DuBois
and DuBois [14]. GFR corrected to a body surface area of 1.73
m2 is called standard GFR.
Statistics. Mann-Whitney's rank sum test for unpaired data
was used for comparison of mean values. After logarithmic
transformation of the ECV values, the regressions of ECV on
body weight and body surface area were calculated by the
method of least squares, and conventional analysis of variance
was used to compare the regressions between diabetics and
controls.
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Results
Individual values of standard GFR and the ratio GFR/ECV in
diabetic patients and the 26 age-matched control patients are
696
GFR and ECV in diabetics 697
Age
years
Body weight
kg
Body surface area
m2
Diabetics (N = 26)
Median 25 63 1.77
Range 17to50 48to97 1.53to2.17
Contro1s (N = 26)
Median 27 66 1.84
Range 18 to 46 56 to 91 1.65 to 2.10
Controlsb (N = 44)
Median 30 70 1.88
Range 18to70 56to95 1.65to2.11
shown in Figure 1. Standard GFR in the diabetic patients
differed significantly from that in the control patients (127 21
mi/mm vs. 107 15 mi/mm, P < 0.001), the same held true for
theratioGFRlECV(O.58 0.l0hr vs. 0.51 0.07hr,P<
0.05).
The regression of log ECV on body weight (Fig. 2) had the
equation y 0.0031x + 3.9333 (SD = 0.0409) in the diabetic
patients, and y = 0.0026x + 3.9510 (SD = 0.0489) in the 44
control patients. The regression lines could be considered to be
parallel so that ECV on the average was 4.1% higher in the
diabetic patients than in the controls for the same body weight
(0.1 <P < 0.2). ECV expressed as percent of body weight in
the diabetic patients differed significantly from that in the
controls (21.4 2.7% vs. 19.5 2.6%, P < 0.01). Calculated
from the regression equations, the relative ECV for the studied
range of body weights varied from 25.2% (bw 48 kg) to 17.7%
(bw 97 kg) in diabetic patients and from 22.3% (bw 56 kg) to
16.6% (bw 95 kg) in control patients.
The regression of log ECV on body surface area (Fig. 2) had
the equation y = 0.2320x + 3.7191 (SD = 0.0405) in the
diabetics, and y = 0.1957x + 3.7669 (SD = 0.0505) in the
controls, the regression lines being parallel so that ECV in the
diabetic patients exceeded ECV in the control patients by 4.4%
for the same body surface area (0.2 <P < 0.3). There was no
significant difference between diabetic and control patients with
respect to ECV corrected to a body surface area of 1.73 m2
(13.26 1.21 1 vs. 12.64 1.46 1, 0.05 <P < 0.1).
In the diabetic patients there was no significant correlation
between ECV and the duration of disease (r =0.14) or between
ECV and the blood glucose concentration (r =
—0.01). The
same held true for standard GFR (r 0.25, r = 0.30).
Discussion
It is generally accepted that GFR is the best single parameter
for assessing renal function. GFR is usually corrected to a
standard surface area of 1.73 m2 when used to compare renal
function between different groups. In the present study the
mean standard GFR in the diabetic patients exceeded signifi-
cantly that of the controls by 19%, a finding which corresponds
to previously reported results in insulin-dependent diabetic
patients examined during moderate hyperglycemia [1—7].
The kidney has many functions, but the most essential is to
regulate the composition and volume of the extracellular fluids.
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Fig. 1. Individual values of glomerular filtration rate corrected to a
body surface area of 1.73 m2 (standard GFR) and of the ratio between
the glomerular filtration rate and the extracellular fluid volume (GFR/
ECV) in 26 diabetic men and 26 normal men. Horizontal bars indicate
the mean values.
Therefore, as first pointed out by McCance and Widdowson
[15], the effectiveness of renal function should be evaluated
according to the purpose it serves. Accordingly, the renal
function has been assessed as the ratio between GFR and ECV.
The GFR/ECV ratio indicates the fraction of the extracellular
fluids that passes the glomerular membranes as an ultrafiltrate
of plasma per unit time, that is, how often that which is to be
regulated (that is, the extracellular fluids) comes into contact
with the regulator (that is, the kidney). Using this principle for
assessment of renal function, the present results indicate that
renal function in diabetic patients is higher than normal in the
sense that the extracellular fluids come into contact with the
kidneys approximately 15% more frequently than normal due to
the increased GFR in connection with a normal ECV. These
findings suggest that the extracellular fluids in diabetic patients
are more effectively regulated than in normal subjects. Studies
made with a comparison between diabetic and normal patients
of the capacity of the kidney to regulate alterations of the
extracellular fluids (for example, after a sodium load) are not,
however, available.
From this and other studies [16—181 it is evident that the
fraction of the body weight made up by ECV declines with
increasing body weight. To compare ECV between two groups
the distribution of body weights thus have to be the same in
both groups when ECY is expressed as a fraction of body
weight. Otherwise the interpretation of the comparison may be
inaccurate. This problem is exemplified by the present study in
which ECV (relative to body weight) in the diabetic patients
differed significantly from that in the controls (21.4 vs. 19.5%);
this difference was mainly due to the lower body weights in the
diabetic patients (compare Table 1 and Fig. 2). To compare
ECV between two groups in which the distribution of body
weights is different, regression analysis as used in the present
study is the method of choice. The results of this analysis
indicate that ECV in diabetics do not differ from normal either
in relation to body weight or in relation to body surface area.
In conclusion, the present study indicates that the renal
function assessed as the ratio between GFR and ECY is
Table 1. Clinical observations on diabetic and control patients GF R/ECV
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significantly higher in insulin-dependent diabetic patients with-
out nephropathy than in normal subjects. Thus the increased
GFR reflects a real hyperfunction while that of acromegaly
(normal pregnancy and obesity) is only apparent because the
ratio GFRJECV is normal.
Summary. To investigate whether the increased GFR in
diabetic patients is related to an increased ECV, GFR ([51Cr]
EDTA clearance) and ECV (distribution volume of [5tCr]
EDTA) was determined in 26 insulin-dependent diabetic men
aged 17 to 50 years (duration of disease 0.1 to 14 years) and
compared to the results in normal men. Mean standard GFR
SD (that is, GFR corrected to a body surface area of 1.73 m2)
was significantly higher in the diabetics than in 26 age-matched
controls (127 21 mI/mm vs. 107 15 mllmin, P < 0.001). The
same held true for the renal function assessed as the ratio
GFR/ECV (0.58 0.10 hr vs. 0.51 0.07, P < 0.05).
Regression analysis showed that the relation between ECV and
body weight and between ECV and body surface area was the
same in the diabetic patients as in 44 controls. The increased
GFR but normal ECV indicates that the GFR alteration in
diabetic patients reflects a real hyperfunction.
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Fig. 2. Comparison ofextracellularfluid volume (ECV) and body weight A and body surface area B in 26 diabetic men and 44 norma/men. The so/-
id /ines indicate the regression lines in diabetics, and the interrupted lines the regression lines in normal subjects.
